Summary
The specificities of the DNA repair enzymeO 6-alkylguanine-DNA alkyltransferase from brain and liver cells of the chick embryo and of DNase I were demonstrated in vitro by their response to substrate DNA pretreated with monofunctional alkylating agents of differentO 6-guanine alkylating ability and some antineoplastic agents. Treatment of DNA with ethidium bromide, Hoechst 33258, doxorubicin, Fe2+/bleomycin, and suramin resulted in a dose-dependent diminution of alkyltransferase activity (DE50 ≈ 5 μg/ml, 15 μg/ml, 5 μg/ml, 5 μg/ml, 100 μg/ml, respectively). Apart from bleomycin, comparable results were obtained with DNase I. Thermal denaturation of the substrate DNA reduced both alkyltransferase and DNase I activity. No effect was seen with X-irradiation. Cisplatin decreased only DNase I activity. Some topoisomerase II and/or gyrase inhibitors remained without significant effects on the alkyltransferase reaction whereas DNA catabolism by DNase I was diminished in a dose-dependent manner (DE50 between 6.5 and 19 μg/ml).
Similar content being viewed by others
Abbreviations
- AT:
-
alkyltransferase
- BB:
-
bisbenzimide
- EB:
-
ethidium bromide
- DOX:
-
doxorubicin
- CDDP:
-
cis-diamminedichloroplatinum (II)
- MMS:
-
methylmethanesulphonate
- EMS:
-
ethylmethanesulphonate
- MNU:
-
methylnitrosourea
- ENU:
-
ethylnitrosourea
References
Barranco SC (1984) Cellular and molecular effects of adriamycin on dividing and nondividing cells. Pharmacol Ther 24:303–319
Boiteux S, Laval F (1985) Repair of O6-methylguanine by mammalian cell extracts, in alkylated DNA and poly(dG-m5dC)·(poly dG-m5dC). Carcinogenesis 6:805–807
Bredberg A, Brant M, Jaszyk M (1991) Ciprofloxacin-induced inhibition of topoisomerase II in human lymphoblastoid cells. Antimicrob Agents Chemother 35:448–450
Brent TP (1986) Inactivation of purified humanO 6-alkylguanineDNA alkyltransferase by alkylating agents or alkylated DNA. Cancer Res 46:2320–2323
Dexter EU, Yamashita TS, Donovan C, Gerson SL (1989) Modulation ofO 6-alkylguanine-DNA alkyltransferase in rats following intravenous administration ofO 6-methylguanine. Cancer Res 49:3520–3524
Dolan ME, Moschel RC, Pegg AE (1990) Depletion of mammalianO 6-alkylguanine-DNA alkyltransferase activity byO 6-benzylguanine provides a means to evaluate the role of this protein in protecton against carcinogenic and therapeutic alkylating agents. Proc Natl Acad Sci USA 87:5368–5372
Fujio C, Chang HR, Tsujimura T, Ishizaki K, Kitamura H, Ikenaga M (1989) Hypersensitivity of human tumor xenografts lackingO 6-alkylguanine-DNA alkyltransferase to the antitumor agent 1-(4-amino-2-methyl-5-pyrimidinyl)methyl-3-(2-chloroethyl)-3- nitrosourea. Carcinogenesis 10:351–356
Haidle CW, Lloyd RS (1979) Bleomycin. Antibiotics 5:123–154
Hogan ME, Roberson MW, Austin RH (1989) DNA flexibility variation may dominate DNase I cleavage. Proc Natl Acad Sci USA 86:9273–9277
Kemper FH, Luepke NP (1986) Toxicity testing by the hen's egg test (HET). Food Chem Toxicol 24:647–648
LaRocca RV, Stein CA, Myers CE (1990) Suramin: prototype of a new generation of antitumor compounds. Cancer Cells 2:106–115
Meer L, Schold SC, Kleihues P (1989) Inhibition of the hepaticO 6- alkylguanine-DNA alkyltransferase in vivo by pretreatment with antineoplastic agents. Biochem Pharmacol 38:929–934
Menichini P, Fronza G, Tornaletti S, Galiègue-Zouitina S, Bailleul B, Loucheux-Lafebvre MH, Abbondandolo A, Pedrini AM (1989) In vitro DNA modification by the ultimate carcinogen of 4-nitroquinoline-1-oxide: influence of superhelicity. Carcinogenesis 10:1589–1593
Müller EG, Yamazaki Z, Zöllner JE, Zahn RK (1973) Action of bleomycin on programmed synthesis. Influence on DNA and RNA nucleases. FEBS Lett 31:217–221
Pegg AE (1990a) MammalianO 6-alkylguanine-DNA alkyltransferase: regulation and importance in response to alkylating carcinogenic and therapeutic agents. Cancer Res 50:6119–6129
Pegg AE (1990b) Properties of mammalianO 6-alkylguanine-DNA transferases. Mutat Res 233:165–175
Pegg AE, Wiest L, Foote RS, Mitra S, Perry W (1983) Purification and properties ofO 6-methylguanine-DNA transmethylase from rat liver. J Biol Chem 258:2327–2333
Scudiero DA, Meyer A, Clatterbuck BE, Mattern MR, Ziolkowski CHJ, Day RS (1984) Sensitivity of human cell strains having different abilities to repairO 6-methylguanine in DNA to inactivation by alkylating agents including chloroethylnitrosoureas. Cancer Res 44:2467–2474
Seki S, Oda T (1984) Differential sensitivity to ethidium bromide of replicative DNA synthesis and bleomycin-induced unscheduled DNA synthesis in permeable mouse sarcoma cells. Experientia 40:869–871
Sierakowska H, Shugar D (1977) Mammalian nucleolytic enzymes. Progr Nucl Acid Res Mol Biol 20:60–130
Singer B, Grunberger D (1983) Molecular biology of carcinogens and mutagens. Plenum, New York
Smith PJ, Lacy M, Debenham RG, Watson JV (1988) A mammalian cell mutant with enhanced capacity to dissociate a bisbenzimidazole dye-DNA complex. Carcinogenesis 9:485–490
Stammberger I, Schmahl W, Nice L (1990) Effects of X-irradiation,N-ethyl-N-nitrosourea or combined treatment onO 6-alkylguanine-DNA alkyltransferase activity in fetal rat brain and liver and the induction of CNS tumours. Carcinogenesis 11:219–222
Tunis M, Regelson W (1963) A comparative study of the inhibiting effects of anionic polyelectrolytes on deoxyribonucleases. Arch Biochem Biophys 101:448–445
Vogel EW (1989) Nucleophilic selectivity of carcinogens as a determinant of enhanced mutation response in excision repair-defective strains in drosophila: effects of 30 carcinogens. Carcinogenesis 10:2093–2106
Wang LG, Setlow RB (1989) Inactivation ofO 6-alkylguanineDNA alkyltransferase in HeLa cells by cisplatin. Carcinogenesis 10:1681–1684
Yarosh DR (1985) The role ofO 6-methylguanine-DNA methyltransferase in cell survival, mutagenesis and carcinogenesis. Mutat Res 145:1–16
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Link, A., Tempel, K. Inhibition ofO 6-alkylguanine-DNA alkyltransferase and DNase I activities in vitro by some alkylating substances and antineoplastic agents. J Cancer Res Clin Oncol 117, 549–555 (1991). https://doi.org/10.1007/BF01613287
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01613287